newdrugapprovals.org
Amgen/Onyx file multiple myeloma drug in US, EU…..a supplemental New Drug Application has now been filed to support the conversion of this to full approval and expand target population.
Carfilzomib synthesis……… supplemental New Drug Application filed Amgen and its subsidiary Onyx Pharmaceuticals have submitted filings for their multiple myeloma drug Kyprol…